Plasmapheresis, an aid in the treatment of patients with active systematic lupus erythematosus?
Houwert, D.A.; Kater, L.; Struyvenberg, A.
Nederlands Tijdschrift Voor Geneeskunde 122(19): 678-681
1978
ISSN/ISBN: 0028-2162 PMID: 148592 Document Number: 127935
Document emailed within 1 workday
Related Documents
Leibowitz, G.; Ben-Yehuda, A.; Naparstek, Y. 1990: Role of plasmapheresis in the treatment of systemic lupus erythematosus Harefuah 118(6): 329-333Simcíková, B.; Opat, P.; Rysánek, K.; Bucek, J.; Lokaj, J.; Podrouzková, D.; Mayer, P. 1985: Initial experience in the treatment of systemic lupus erythematosus using plasmapheresis Casopis Lekaru Ceskych 124(35): 1097-1101
Graf, N.; Bambauer, R.; Jost, W.; Schäfer, M. 1990: Status of plasmapheresis and cyclosporin a in the treatment of systemic lupus erythematosus Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 138(7): 395-398
Cui, H.L.; Ma, L.; Zhu, R.Q. 1990: Therapeutic plasmapheresis in systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 29(7): 422
Horwitz, D.A.; Juul-Nielsen, K. 1977: Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells Clinical and Experimental Immunology 30(3): 370-378
Chan, E.Y.; Ko, S.C.; Lau, C.S. 1997: Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus Asian Pacific Journal of Allergy and Immunology 15(1): 3-7
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Meffert, H.; Böhm, F.; Apostoloff, E.; Kramm, H.J. 1980: Plasmapheresis therapy in severe lupus erythematosus D.N.A. serum antodies and erythrocyte sedimentation rate for therapy control Dermatologische Monatschrift 166(5): 331-335
Lee, Y.Ho.; Lee, H-Soon.; Choi, S.Jae.; Ji, J.Dae.; Song, G.Gyu. 2012: Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis Clinical and Experimental Rheumatology 30(2): 262-265
Maneta-Peyret, L.; Previsani, C.; Sultan, Y.; Bezian, J.H.; Cassagne, C. 1991: Autoantibodies against all the phospholipids: a comparative systematic study with systemic lupus erythematosus and healthy sera European Journal of Clinical Chemistry and Clinical Biochemistry 29(1): 39-43
Sultanova, T.Zh. 2009: Assessment of pharmacological correction in the treatment of patients with systemic lupus erythematosus Likars'ka Sprava 2009(7-8): 86-89
van Vollenhoven, R.F.; Morabito, L.M.; Engleman, E.G.; McGuire, J.L. 1998: Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months Journal of Rheumatology 25(2): 285-289
Leong, K.P.; Tee, N.W.; Yap, W.M.; Chee, T.S.; Koh, E.T. 2000: Nocardiosis in patients with systemic lupus erythematosus. the Singapore Lupus Study Group Journal of Rheumatology 27(5): 1306-1312
Carsons, S. 1987: High levels of fibronectin fragments in the plasma of a patient with active systemic lupus erythematosus Journal of Rheumatology 14(5): 1052-1054
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Pothinamthong, P.; Janjumratsang, P. 2012: A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index Journal of the Medical Association of Thailand 95(7): 933-940
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Szegedi, G.; Nagy, E.; Tamási, P.; Gergely, P.; Sonkoly, I. 1976: Studies on T and B lymphocytes in the peripheral blood of discoid lupus erythematosus patients with and without chloroquine treatment Acta Dermato-Venereologica 56(1): 47-49
Camara, I.; Sciascia, S.; Simoes, J.; Pazzola, G.; Salas, V.; Karim, Y.; Roccatello, D.; Cuadrado, M.J. 2014: Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre Clinical and Experimental Rheumatology 32(1): 41-47